Referenzen

EMEA (2009) Assessment Report on Curcuma longa L. Rhizoma. In Committee on herbal medicinal products.

Mazieiro et al. (2018), Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases?, J Med Food. 2018 Jun 29. doi: 10.1089/jmf.2017.0146

Datta et al. (2018), Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells, PNAS August 7, 2018 115 (32) 8087-8092

Banerjee (2018), Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2, PNAS August 7, 2018 115 (32) 8155-8160

Galindo et al. (2018), Crystal structure reveals how curcumin impairs cancer, https://www.sciencedaily.com/releases/2018/07/180709161543.htm

Gupta, S.C., Patchva, S. and Aggarwal, B.B. (2013) Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J, 15, 195-218.

Jäger, R., Lowery, R.P., Calvanese, A.V., Joy, J.M., Purpura, M. and Wilson, J.M. (2014) Comparative absorption of curcumin formulations. Nutrition Journal, 13, 1-8.

Lao, C.D., Ruffin, M.T., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Boggs, M.E., Crowell, J., Rock, C.L. and Brenner, D.E. (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med, 6.